The U.S. Food and Drug Administration has updated the risk classification for a nationwide recall of children’s ibuprofen.

Advantage plans do a better job than standalone Part D policies, albeit with important gap ...

“Start low, go slow.” Geriatric pharmacology texts and recent systematic reviews (e.g., on dosing of oncology drugs) warn ...

SELECT was a large study focused on obesity and cardiovascular disease in people without type 2 diabetes, but it included kidney outcomes as a secondary end point. The data showed that semaglutide ...

The Food and Drug Administration has announced the recall of children's ibuprofen after complaints of the presence of a ...

Ocean City police reported a nearly 38% drop in overall criminal activity last year, driven by sharp declines in assault, theft and drug cases, even as robberies and a handful of other low-volume ...

Alcohol and tobacco cause far more harms to people who consume them, and to society overall, than marijuana does, according ...

Wiley, a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation and learning, today announced the 2026 release of Mass Spectra of ...

A rapist at HMP Isle of Wight has had his sentence extended and deportation date put back after officers found a phone and ...

DTAB recommends certain exemptions to specific categories from revised Schedule M norms: Gireesh Babu, New Delhi Monday, March 16, 2026, 08:00 Hrs [IST] The Drugs Technical Adviso ...

The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...